🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness and Cost-Effectiveness of a Digital Care Pathway and Asynchronous Communication for Patients With Hypertension

RecruitingNAAges 30 Years - 74 YearsAllWellbeing Services County of Pirkanmaa
NCT07812350 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if digital care pathway (DCP) and digital non-real-time messaging, in other words, asynchronous communication (AC) with nurse works to treat high blood pressure in adults in primary care. It will also learn if DCP and AC are good value for money. The main questions it aims to answer are: * Does DCP and AC lower systolic blood pressure? * Are DCP and AC good value for money in treating high blood pressure? Researchers will compare usual care plus DCP and usual care plus DCP with AC to usual care only to see if DCP and AC works to treat high blood pressure. Participants will: * Get usual care or usual care plus DCP or usual care plus DCP with AC for 6 months * Visit the study nurse at the start of the trial and after 6 months for checkup and tests which include usual laboratory tests for high blood pressure * Answer online survey questions and

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * a diagnosis of hypertension for at least 3 months * an office blood pressure of ≥140/90 mmHg at baseline * access to a smartphone and the ability to use strong electronic identification for application login * ability to measure home blood pressure * ability to take care of the personal medication Exclusion Criteria: * unwillingness to participate in the study * secondary hypertension or hypertensive crisis (office blood pressure \>200/130 mmHg) * atrial fibrillation * stage 4 or 5 chronic kidney disease (eGFR \<30 mL/min/1.73 m²) * a life expectancy of less than 1 year * pregnancy or breastfeeding * a clearly impaired ability to use the study interventions or participate in the study, as determined by a healthcare professional (e.g., insufficient Finnish language proficiency, dementia, psychiatric illness, or sensory impairments)
💊

What it tests

  • Digital care pathway for hypertension
  • Asynchronous communication with nurse
📍

Where

6 sites
Akaa health and social services centre, The Wellbeing Services County of Pirkanmaa
Akaa, Finland
Sastamala health and social services centre, The Wellbeing Services County of Pirkanmaa
Sastamala, Finland
Hatanpää health and social services centre, The Wellbeing Services County of Pirkanmaa
Tampere, Finland
Hervanta health and social services centre, The Wellbeing Services County of Pirkanmaa
Tampere, Finland
Linnainmaa health and social services centre, The Wellbeing Services County of Pirkanmaa
Tampere, Finland
Valkeakoski health and social services centre, The Wellbeing Services County of Pirkanmaa
Valkeakoski, Finland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy